Nystatin 100,000 units/mL Oral Suspension
Brand names: Nystan
Nystatin oral suspension is a topical antifungal used to treat oral and oropharyngeal candidiasis (thrush).
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It binds to ergosterol in the fungal cell membrane, creating pores that cause leakage of cell contents and fungal cell death; it acts locally within the mouth and gut.
Prescribing in practice
- It is essentially not absorbed from the gut, so systemic effects are minimal and it acts only on contact — adequate mouth exposure is essential for efficacy.
- Hold the suspension in the mouth, in contact with the affected areas, before swallowing, and use after food.
- Continue treatment for the full course, typically for a period after lesions clear, to prevent relapse.
Monitoring
Routine laboratory monitoring is not required; review clinically for resolution of lesions and consider an alternative or underlying-cause review if there is no response.
Counselling the patient
- Keep the liquid in your mouth and swish it around the affected areas for as long as you can before swallowing.
- Use it after food and avoid eating or drinking for a short time afterwards so it stays in contact.
- Finish the whole course even once the white patches have cleared.
Evidence & guidelines
A long-established topical treatment for oral candidiasis recommended in UK primary-care guidance, with good local efficacy and minimal systemic exposure.
Reference: NICE CKS Oral Candidiasis; PHE Candidiasis Guidelines; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- DOAC Score for Selecting Direct Oral Anticoagulant in Non-Valvular AF · Anticoagulation
- Weight-Based Levothyroxine Dose Calculator · Thyroid
- Ho Index for Predicting Response to Medical Therapy in IBD · Inflammatory Bowel Disease
- Deauville Score (5-Point Scale) for Lymphoma Response · Treatment Response
- IPS-E — International Prognostic Score for Early CLL · Leukaemia
- SLiM-CRAB Criteria for Multiple Myeloma · Myeloma
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020